This strongly suggested that all the sequences of cDNAs were identical, or at least nearly identical, and no mutations to the fragment of the gene encoding PKR-BD were introduced during the therapy (Fig. 3b). The gene discussed is EIF2AK2; the disease is Behcet disease.